CT & MRI company Medic Vision Imaging Solutions Ltd revealed on Tuesday that it has passed the US Food and Drug Administration (FDA) clearance for latest product, iQMR (intelligent Quick MR), to save cost, improve its productivity and boost patients experience and profitability.
The company said the new iterative image reconstruction technology enhances noisy MRI images and significantly increases SNR (signal to noise ratio). The new technology's capabilities enable the use of short MRI protocols and allow increased productivity, fewer repeating scans as well as better patient's experience.
Concurrently, the iQMR supports MRI scanners of all vendors and models, according to the company.
Following the US FDA's clearance, the company will now launch the iQMR at the upcoming ASNR 56th Annual Meeting. Additionally, Prof Lawrence N Tanenbaum, MD, FACR, VP and director of CT, MR & Advanced Imaging at RadNet, will present the results of a clinical study demonstrating the ability to reduce routine brain exam scan time by 30% without adversely affecting image quality using iQMR.
US FDA accepts IND application for AskBio's AB-1009
EspeRare and n-Lorem partner to expand European access to ASO therapies for rare genetic diseases
Bionpharma and STEERLife's Etravirine tablets approved by US FDA
Kestra partners with Biobeat to add cuffless blood pressure monitoring to wearable defibrillator
argenx secures FDA priority review for VYVGART in seronegative myasthenia gravis
Abbisko Therapeutics reports US FDA acceptance of pimicotinib NDA
Formosa Pharmaceuticals licenses APP13007 ophthalmic therapy to Samil for South Korea
Summit Therapeutics submits FDA application for ivonescimab in EGFR-mutated lung cancer
Sanofi's Teizeild approved in EU to delay stage 3 type 1 diabetes